# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-25-000023
Filing Date
2025-04-25
Accepted
2025-04-25 16:10:43
Documents
18
Period of Report
2025-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lsta-20250425.htm iXBRL | DEF 14A | 732150
3 |  | lsta-20250425_g1.jpg | GRAPHIC | 16409
4 |  | lsta-20250425_g2.jpg | GRAPHIC | 7742
5 |  | lsta-20250425_g3.jpg | GRAPHIC | 106548
6 |  | lsta-20250425_g4.jpg | GRAPHIC | 100150
7 |  | lsta-20250425_g5.jpg | GRAPHIC | 4452041
8 |  | lsta-20250425_g6.jpg | GRAPHIC | 4094354
| Complete submission text file | 0000320017-25-000023.txt |  | 19123903

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lsta-20250425.xsd | EX-101.SCH | 920
20 | EXTRACTED XBRL INSTANCE DOCUMENT | lsta-20250425_htm.xml | XML | 93890

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 25874053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)